1 / 23

Personalizing Care for ALK-Positive Lung Cancer Patients: Current Concepts, Treatments & Future Directions

Discover the latest strategies in individualized care for ALK-translocated advanced NSCLC patients, including ALK-targeted treatments, monitoring adverse events, managing CNS metastases, and screening for ALK rearrangements in squamous NSCLC.

maurizio-noonan
Download Presentation

Personalizing Care for ALK-Positive Lung Cancer Patients: Current Concepts, Treatments & Future Directions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Current Concepts in Individualized Care of ALK-Translocated Advanced NSCLC

  2. Educational Objectives

  3. Patient Case 1

  4. Patient Case 1 (cont)

  5. ALK Fusion Genes

  6. ALK+ NSCLC

  7. ALK-Targeted Treatments

  8. First-Line Crizotinib

  9. Crizotinib Adverse Events

  10. Monitoring

  11. Next Generation ALK InhibitorsCrizotinib-Naive Patients

  12. Future Directions for Frontline Therapy

  13. Patient Case 2

  14. CNS Metastases

  15. Recurrence

  16. Ceritinib and AlectinibEfficacy in Crizotinib-Treated Patients

  17. Ceritinib and AlectinibToxicity

  18. Managing Brain Metastases

  19. Screening for ALK Rearrangements in Squamous NSCLC

  20. Future Directions

  21. Abbreviations

  22. Abbreviations (cont)

  23. Abbreviations (cont)

More Related